| Authors: |
Malherbe DC; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Galveston National Laboratory, Galveston, TX, USA.; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, USA., Domi A; GeoVax Inc, Atlanta, GA, USA., Hauser MJ; GeoVax Inc, Atlanta, GA, USA., Atyeo C; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Fischinger S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Hyde MA; Galveston National Laboratory, Galveston, TX, USA., Williams JM; Galveston National Laboratory, Galveston, TX, USA., Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Guirakhoo F; GeoVax Inc, Atlanta, GA, USA.; VAXXINITY, Dallas, TX, USA., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA. alexander.bukreyev@utmb.edu.; Galveston National Laboratory, Galveston, TX, USA. alexander.bukreyev@utmb.edu.; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA. alexander.bukreyev@utmb.edu. |
